Celularity acquires Rebound product from Sequence Lifescience [Seeking Alpha]
Celularity Inc. - Class A (CELU)
Company Research
Source: Seeking Alpha
full thickness placental-derived allograft matrix product, from Sequence LifeScience. Source: Press Release More on Celularity Financial information for Celularity Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
CELU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELU alerts
High impacting Celularity Inc. - Class A news events
Weekly update
A roundup of the hottest topics
CELU
News
- Celularity files to sell 6.52M shares of Class A common stock for holders [Seeking Alpha]Seeking Alpha
- MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDsGlobeNewswire
- Celularity Inc. Announces Resolution of Nasdaq Listing Compliance MatterGlobeNewswire
- Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023GlobeNewswire
- Celularity Inc. Announces Receipt of Nasdaq Notification [Yahoo! Finance]Yahoo! Finance
CELU
Sec Filings
- 2/14/25 - Form SCHEDULE
- 2/13/25 - Form FWP
- 2/13/25 - Form S-1/A
- CELU's page on the SEC website